Search for: "Biogen Idec, Inc." Results 41 - 60 of 113
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Dec 2011, 9:02 am by Shane Cortesi
Biogen Idec, the three patents at issue were related to a method of reducing the risk of chronic immune-mediated disorders by choosing a particular immunization schedule. [read post]
19 Sep 2011, 3:17 am by Marie Louise
Biogen IDEC (Patent Baristas) Debate continues concerning importing limitations from specification into claims – Retractable Techs., Inc. v. [read post]
16 Sep 2011, 1:34 pm
Biogen IDEC, Nos. 2006-1634, 2006-1649, 2011 WL 3835409, at *6 (Fed. [read post]
10 Sep 2011, 4:09 am by Gregory Dell
Disability Blog & Cases: Massachusetts Disability Attorney filed lawsuit against the Aetna Life Insurance Company on behalf of Biogen Idec, Inc’s IT Technical Ops Lead for denial long term disability benefits In the disability lawsuit of Joseph Mcdonough Vs Aetna Life Insurance Company, HM Life Insurance Company, Biogen Idec, Inc. [read post]
10 Sep 2011, 12:32 am by Marie Louise
(Spicy IP) (Spicy IP) US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al / ????????????????????????? [read post]
8 Sep 2011, 9:59 pm by Patent Docs
Biogen IDEC is a separate explication of "additional views" by Chief Judge Rader (at right) joined by Judge Newman. [read post]
7 Sep 2011, 9:29 am by Stephen Jenei
In Classen Immunotherapies, Inc. v. [read post]
7 Sep 2011, 8:03 am by Stephen Jenei
Biogen IDEC by pondering various ways that crafty patent drafters sneak ineligible patent subject matter into their claims. [read post]
7 Sep 2011, 4:22 am by Marie Louise
  Highlights this week included: US: CAFC: Immunisation methods are patent eligible: Classen Immunotherapies, Inc v Biogen IDEC et al (Inventive Step) (Orange Book Blog) (Patently-O) (Patent Docs) (Patent Docs) (IPBiz) (Patent Law Practice Center) (Patent Baristas) US: FTC issues long-awaited final report on authorized generics; report examines both the short-term effects and long-term impact on competition and drug prices (FDA Law Blog) (Orange Book Blog)  … [read post]
6 Sep 2011, 9:55 pm by Patent Docs
Biogen IDEC engendered a strong dissent from Judge Moore on almost every aspect of that decision. [read post]